MedPath

A Clinical Trial to study the effect of drug Dashang Sunti lepa in management of joint swelling and pain.

Phase 2
Completed
Conditions
Health Condition 1: M00-M99- Diseases of the musculoskeletal system and connective tissue
Registration Number
CTRI/2021/05/033510
Lead Sponsor
Vd Shweta Santosh Naik
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
34
Inclusion Criteria

1.All Patient presenting with sign and symptoms of sandhi shoth and shula will be selected.

2. Patients of agantuja shotha without fracture will be included in Study.

3.Patients of either sex in age group of 20 -60 years will be included in study.3.4.Uncomplicated cases of Sandhi Shotha and Shula will be selected.

5.Patients willing to participate in the trial will be included in study.

Exclusion Criteria

1.Patients age less than 20yrs and more than 60 yrs will be excluded.

2. Patients having complications of Sandhi Shoth and Shula like tuberculosis, bone metastasis, psoriatic arthritis and bony deformities of joints (viz.varus/valgus) will be excluded.

3.Patients having pleural effusion, severe anemia,accelerated hypertension, renal failure and chronic cardiac failure will be excluded.

4.Those patients not willing to be part of trial and not giving written consent will be excluded.

5.Patients undergoing regular treatment for other severe illnesses will be excluded.

6.Patients on prolonged corticosteroids will be excluded.

_______________

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath